Please use this identifier to cite or link to this item:
|Title:||A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma|
|Author:||Campayo Guillaumes, Marc|
Navarro Ponz, Alfons
Viñolas Segarra, Núria
Tejero Villalba, Rut
Muñoz García, Carmen
Díaz Sánchez, Tania
Marrades Sicart, Ramon Ma.
Cabanas, Maria L.
Gimferrer Garolera, José Ma.
Ramírez Ruz, J. (José)
Monzó Planella, Mariano
|Publisher:||Public Library of Science (PLoS)|
|Abstract:||MicroRNAs (miRNAs) play an important role in carcinogenesis through the regulation of their target genes. miRNA-related single nucleotide polymorphisms (miR-SNPs) can affect miRNA biogenesis and target sites and can alter microRNA expression and functions. We examined 11 miR-SNPs, including 5 in microRNA genes, 3 in microRNA binding sites and 3 in microRNA-processing machinery components, and evaluated time to recurrence (TTR) according to miR-SNP genotypes in 175 surgically resected non-small-cell lung cancer (NSCLC) patients. Significant differences in TTR were found according to KRT81 rs3660 (median TTR: 20.3 months for the CC genotype versus 86.8 months for the CG or GG genotype; P = 0.003) and XPO5 rs11077 (median TTR: 24.7 months for the AA genotype versus 73.1 months for the AC or CC genotypes; P = 0.029). Moreover, when patients were divided according to stage, these differences were maintained for stage I patients (P = 0.002 for KRT81 rs3660; P<0.001 for XPO5 rs11077). When patients were divided into sub-groups according to histology, the effect of the KRT81 rs3660 genotype on TTR was significant in patients with squamous cell carcinoma (P = 0.004) but not in those with adenocarcinoma. In the multivariate analyses, the KRT81 rs3660 CC genotype (OR = 1.8; P = 0.023) and the XPO5 rs11077 AA genotype (OR = 1.77; P = 0.026) emerged as independent variables influencing TTR. Immunohistochemical analyses in 80 lung specimens showed that 95% of squamous cell carcinomas were positive for KRT81, compared to only 19% of adenocarcinomas (P<0.0001). In conclusion, miR-SNPs are a novel class of SNPs that can add useful prognostic information on the clinical outcome of resected NSCLC patients and may be a potential key tool for selecting high-risk stage I patients. Moreover, KRT81 has emerged as a promising immunohistochemical marker for the identification of squamous cell lung carcinoma.|
|Note:||Reproducció del document publicat a: 10.1371/journal.pone.0022509|
|It is part of:||PLoS One, 2011, vol. 6, num. 7, p. e0022509|
|Appears in Collections:||Articles publicats en revistes (Fonaments Clínics)|
Files in This Item:
|597285.pdf||2.87 MB||Adobe PDF||View/Open|
This item is licensed under a Creative Commons License